Cargando…
Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L
SIMPLE SUMMARY: Chromosomal translocations involving the mixed lineage leukemia (MLL) gene generate potent fusion oncogenes and cause acute myeloid leukemia or lymphocytic leukemia, which account for ~75% infant and 5–10% child/adult acute leukemia cases with a poor prognosis (5-year survival rates...
Autores principales: | Li, Xin, Wu, Xiaowei, Nie, Shenyou, Zhao, Jidong, Yao, Yuan, Wu, Fangrui, Mishra, Chandra Bhushan, Ashraf-Uz-Zaman, Md, Moku, Bala Krishna, Song, Yongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650850/ https://www.ncbi.nlm.nih.gov/pubmed/37958457 http://dx.doi.org/10.3390/cancers15215283 |
Ejemplares similares
-
Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth
por: Wu, Fangrui, et al.
Publicado: (2021) -
MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins
por: Komata, Yosuke, et al.
Publicado: (2023) -
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
por: Garnar-Wortzel, Leopold, et al.
Publicado: (2021) -
HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
por: Takahashi, Satoshi, et al.
Publicado: (2021) -
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
por: Li, Xin, et al.
Publicado: (2022)